Form 8-K · Current Report · Filed 2026-09-17
Medtronic Corrects Prospectus for Exchange Offer
On September 17, 2026, Medtronic plc filed an 8-K to correct a typographical error in the prospectus related to the Exchange Offer.
- Filer
- Medtronic plc MDT · NYSE
- Filed
- Accession
- 0001628280-26-062505
- CIK
- 0001613103
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The error was in the description of guaranteed delivery procedures, which has been revised to clarify the expiration time for a notice of guaranteed delivery. The corrected information is now that the guaranteed delivery period will expire at 5:00 p.m., New York City time, on the second NYSE trading day after the date of execution of such notice of guaranteed delivery.
Items reported
Reported Item
Market reaction
Close before filing
$92.60
Since filing
+0.0%
Latest close
$92.60
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MDT reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, MDT insiders reported 29 Form 4 transactions — net selling of $239K.
About Medtronic plc
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and related services for a broad range of chronic and acute health conditions. Headquartered in Dublin, Ireland, and founded in 1949, Medtronic focuses on technologies used by hospitals, clinics, and physicians worldwide. The company operates through four main areas: its Cardiovascular Portfolio, offering products such as heart valves, stents, pacemakers, and defibrillators; its Neuroscience Portfolio, which provides spinal fixation systems, neurostimulation devices, and neurovascular products; its Medical Surgical Portfolio, supplying advanced surgical instruments, energy-based devices, and visualization tools; and its Diabetes Operating Unit, which delivers insulin pumps, continuous glucose monitoring systems, and related consumables. Medtronic plays a significant role in the healthcare sector by providing solutions that support the diagnosis, monitoring, and treatment of complex conditions, serving healthcare providers and patients across the United States, Europe, Japan, and other international markets.
Never miss another MDT filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.